PO-0733 Minimal Invasive Surfactant Therapy: Cui Bono?
BackgroundMinimal invasive surfactant therapy (MIST) is associated with a diminished need for mechanical ventilation. Insufficient insight exists in predictive success factors.AimDefining success factors for MIST.MethodsFrom 2011–2013 preterm infants admitted to the NICU with respiratory distress an...
Gespeichert in:
Veröffentlicht in: | Archives of disease in childhood 2014-10, Vol.99 (Suppl 2), p.A495-A495 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | BackgroundMinimal invasive surfactant therapy (MIST) is associated with a diminished need for mechanical ventilation. Insufficient insight exists in predictive success factors.AimDefining success factors for MIST.MethodsFrom 2011–2013 preterm infants admitted to the NICU with respiratory distress and radiographically established IRDS with FiO2 |
---|---|
ISSN: | 0003-9888 1468-2044 |
DOI: | 10.1136/archdischild-2014-307384.1373 |